These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3674032)

  • 1. Visual incompatibility of dacarbazine and heparin.
    Nelson RW; Young R; Lamnin M
    Am J Hosp Pharm; 1987 Sep; 44(9):2028. PubMed ID: 3674032
    [No Abstract]   [Full Text] [Related]  

  • 2. Compatibility of drugs with a heparin-containing neonatal total parenteral nutrient solution.
    Schilling CG
    Am J Hosp Pharm; 1988 Feb; 45(2):313-4. PubMed ID: 3129935
    [No Abstract]   [Full Text] [Related]  

  • 3. Dobutamine-heparin mixture inadvisable.
    Hasegawa GR; Eder JF
    Am J Hosp Pharm; 1984 Dec; 41(12):2588, 2590. PubMed ID: 6517078
    [No Abstract]   [Full Text] [Related]  

  • 4. Visual compatibility of premixed theophylline or heparin with selected drugs for i.v. administration.
    Kershaw BP; Monnier HL; Mason JH
    Am J Hosp Pharm; 1993 Jul; 50(7):1360, 1362-3. PubMed ID: 8362868
    [No Abstract]   [Full Text] [Related]  

  • 5. [Incompatibility of drugs designed for intravascular use].
    Berglund A; Kolmodin CG; Hamfelt A; Lundgren A
    Lakartidningen; 1966 Jan; 63(4):296-7. PubMed ID: 5913320
    [No Abstract]   [Full Text] [Related]  

  • 6. Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy.
    Robinson JL; Tawfik G; Saxinger L; Stang L; Etches W; Lee B
    J Antimicrob Chemother; 2005 Nov; 56(5):951-3. PubMed ID: 16155063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gentamicin on heparin activity.
    Tyler LS; Rehder TL; Davis RB
    Am J Hosp Pharm; 1981 Apr; 38(4):537-40. PubMed ID: 7282683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dacarbazine].
    van Nispen tot Pannerden EB; van Sorge AA
    Ned Tijdschr Geneeskd; 1984 Dec; 128(49):2321. PubMed ID: 6514052
    [No Abstract]   [Full Text] [Related]  

  • 9. Compatibility of haloperidol lactate and heparin sodium.
    Solomon DA; Nasinnyk KK
    Am J Hosp Pharm; 1982 May; 39(5):843-4. PubMed ID: 7081260
    [No Abstract]   [Full Text] [Related]  

  • 10. Unusual local cutaneous reaction to dacarbazine.
    Koehn GG; Balizet LB
    Arch Dermatol; 1982 Dec; 118(12):1018-9. PubMed ID: 6216855
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-response relationship to dacarbazine demonstrated in a patient with malignant melanoma.
    Hoelzer KL; Harrison BR; Luedke DW; Mahanta B
    Cancer Treat Rep; 1986 Oct; 70(10):1211-2. PubMed ID: 3756941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy in advanced malignant melanoma. Results of a controlled trial comparing a combination of dacarbazine (DTIC) and detorubicin with dacarbazine alone].
    Chauvergne J; Bui NB; Cappelaere P; Gary-Bobo J; Guerrin J; Armand JP; Durand M
    Sem Hop; 1982 Dec; 58(46):2697-701. PubMed ID: 6297068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination of dacarbazine, cisplatin and interferon alpha in the treatment of metastatic melanoma].
    Tessier MH; Mansat E; Legoux B; Litoux P; Dreno B
    Ann Dermatol Venereol; 1996; 123(9):538-42. PubMed ID: 9615103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Search for drug interactions between the antitumour agent DTIC and other cytotoxic agents [proceedings].
    Horton JK; Stevens MF
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():64P. PubMed ID: 42741
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemoembolization followed by systemic chemotherapy with dacarbazine for a metastatic glucagonoma].
    D'Alteroche L; Viguier J; Maillard H; Debbabi S; Certin M; Metman EH
    Gastroenterol Clin Biol; 2000 Jan; 24(1):132-3. PubMed ID: 10755862
    [No Abstract]   [Full Text] [Related]  

  • 16. Compatibility of heparin sodium and morphine sulfate.
    Baker DE; Yost GS; Craig VL; Campbell RK
    Am J Hosp Pharm; 1985 Jun; 42(6):1352-5. PubMed ID: 4014252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleomycin compatibility with selected intravenous medications.
    Dorr RT; Peng YM; Alberts DS
    J Med; 1982; 13(1-2):121-30. PubMed ID: 6181179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of bio-metal Fe(III) in anticancer effect of dacarbazine.
    Shukla J; Pitre KS
    Indian J Physiol Pharmacol; 1998 Apr; 42(2):223-30. PubMed ID: 10225049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of heparin and low-molecular mass heparin in a new implantable medication pump.
    Schmid MG; Sadjak A; Likar R; Wintersteiger R
    Arzneimittelforschung; 1998 Sep; 48(9):910-3. PubMed ID: 9793617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micronucleus analysis in peripheral blood lymphocytes from melanoma patients treated with dacarbazine.
    Miele M; Bonassi S; Bonatti S; Martini E; Miglio L; Ottaggio L; Queirolo P; Sertoli M; Abbondandolo A
    Anticancer Res; 1998; 18(3B):1967-71. PubMed ID: 9677451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.